Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Mindray Medical Grows Revenues 14.5% in 2013

publication date: Mar 4, 2014
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Mindray Medical, China’s largest medical device company, reported revenues climbed 14.5% to $1.2 billion during 2013, and net income was up 25% at $225 million (GAAP). Western European markets were especially strong, rising more than 20%. Mindray forecast that sales for 2014 would rise at least 15%, but non-GAAP net income will remain at 2013 levels. During 2014, the company expects to invest in sales, marketing and distribution as well as product innovation. More details....

Stock Symbol: (NYSE: MR)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...